DrugNews Alerts of Significant Rise in Lawsuits Alleging Pradaxa Bleeding

Share Article

http://www.DrugNews.net is the web’s premier source for prescription device warnings, research, side effects and legal news. Visit the DrugNews Center today.

News Image
The resource center added a study from the Institute for Safe Medication Practices suggesting patients suffering bleeding from Pradaxa may be nearly 5 times as likely to die than those with bleeding from warfarin.

The prescription drug resource center DrugNews.net is announcing updated information for patients taking the blood thinner Pradaxa. Recent court records show the number of lawsuits filed alleging the drug caused serious or fatal internal bleeding rose 22% in the past month*.

DrugNews was created to bring the latest warnings, recalls, studies and legal news to those taking popular prescription drugs. Visitors can see if others are experiencing similar side effects and decide if they need legal advice.

Pradaxa is a blood thinner approved by the FDA in 2010 as a stroke preventative for patients with atrial fibrillation. Experts disagree, however, about its risks for internal bleeding.

The resource center added a study from the Institute for Safe Medication Practices suggesting patients suffering bleeding from Pradaxa may be nearly 5 times as likely to die than those with bleeding from warfarin**. A study from the Netherlands also shows patients taking blood thinners like Pradaxa may be 55% more likely to suffer internal bleeding***.

Regardless, the FDA has advised Pradaxa is no more dangerous than traditional blood thinner warfarin****.

With the growing number of patients who have filed a Pradaxa lawsuit alleging internal bleeding, cases were consolidated to a special federal court in Illinois. The case is formally known as MDL No. 2385, IN RE: Pradaxa Product Liability Litigation, Southern District of Illinois.

Now, DrugNews has learned the latest court records from the Judicial Panel on Multidistrict Litigation show the number of cases filed has increased from 1,133 on July 10th to 1,389 on August 15, a rise of over 22%*.

Anyone affected by internal bleeding after taking Pradaxa is encouraged to visit DrugNews.net or speak with a lawyer about their legal options. However, due to the specialized nature of federal drug injury cases, DrugNews only recommends lawyers who have already handled Pradaxa lawsuits.

Visit http://www.DrugNews.net today for more information on the research, side effects and litigation news related to Pradaxa and other drugs, or to speak with a lawyer.

*Judicial Panel on Multidistrict Litigation, 8/15/13; jpml.uscourts.gov/sites/jpml/files/Pending_MDL-Dockets_By_District-August-15-2013.pdf
**Institute for Safe Medication Practices, 1/9/13; ismp.org/quarterwatch/pdfs/2012Q2.pdf
***Gastroenterology, July 2013; gastrojournal.org/article/S0016-5085(13)00290-4/fulltext
****FDA, 11/2/12; http://www.fda.gov/Drugs/DrugSafety/ucm326580.htm

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Patient Advocate
DrugNews
888-987-4866
Email >
Visit website